Respiratory disorders associated with dystonia

Movement Disorders

Volumn 27, Issue 14, 2012, Pages 1816-1819

  Mehanna, Raja ^a   Jankovic, Joseph ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Dyspnea; Dystonia; Movement disorders; Respiratory

Indexed keywords

ALPRAZOLAM; BENZATROPINE; BOTULINUM TOXIN; BUSPIRONE; CLONAZEPAM; QUETIAPINE; RISPERIDONE; TETRABENAZINE;

ADULT; AGED; ARTICLE; BLEPHAROSPASM; CERVICAL DYSTONIA; CLINICAL ARTICLE; CRANIAL CERVICAL DYSTONIA; DISEASE ASSOCIATION; DYSPNEA; DYSTONIA; FEMALE; FLUOROSCOPY; FOLLOW UP; HUMAN; LARYNGOSCOPY; MALE; MASSAGE; MUSCLE CONTRACTION; MUSCLE RELAXATION; PRIORITY JOURNAL; QUACKERY; RESPIRATORY TRACT DISEASE; SPASMODIC DYSPHONIA; TRACHEOSTOMY; TREATMENT RESPONSE; WRITER'S CRAMP;

ADULT; AGED; BOTULINUM TOXINS, TYPE A; DIAPHRAGM; DYSPNEA; DYSTONIC DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84871749768     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25269     Document Type: Article

References (21)

1. Tarsy D, Simon DK. Dystonia. N Engl J Med 2006; 355: 818-827.
2. Ozelius LJ, Lubarr N, Bressman SB. Milestones in dystonia. Mov Disord 2011; 26: 1106-1126.
3. Jankovic J. Treatment of hyperkinetic movement disorders. Lancet Neurol 2009; 8: 844-856.
4. Zwirner P, Dressler D, Kruse E. Spasmodic laryngeal dyspnea: a rare manifestation of laryngeal dystonia. Eur Arch Otorhinolaryngol 1997; 254: 242-245.
5. Tanner K, Roy N, Merrill RM, Sauder C, Houtz DR, Smith ME. Spasmodic dysphonia: onset, course, socioemotional effects, and treatment response. Ann Otol Rhinol Laryngol 2011; 120: 465-473.
6. Gallivan GJ, Hoffman L, Gallivan KH. Episodic paroxysmal laryngospasm: voice and pulmonary function assessment and management. J Voice 1996; 10: 93-105.
7. Braun N, Abd A, Baer J, Blitzer A, Stewart C, Brin M. Dyspnea in dystonia. A functional evaluation. Chest 1995; 107: 1309-1316.
8. Fève A, Angelard B, Lacau St Guily J. Laryngeal tardive dyskinesia. J Neurol 1995; 242: 455-459.
9. Lagueny A, Burbaud P, Le Masson G, Bergouignan FX, Ferrer X, Julien J. Involvement of respiratory muscles in adult-onset dystonia: a clinical and electrophysiological study. Mov Disord 1995; 10: 708-713.
10. Blitzer A, Brin MF. Laryngeal dystonia: a series with botulinum toxin therapy. Mov Disord 2007; 22: 673-678.
11. Jankovic J. Treatment of dystonia. Lancet Neurol 2006; 5: 864-872.
12. Grillone GA, Blitzer A, Brin MF, Annino DJ, Jr. Saint-Hilaire M.-H. Treatment of adductor laryngeal breathing dystonia with botulinum toxin type A. Laryngoscope 1994; 104: 30-32.
13. Klap P, Cohen M, van Prooyen Keyzes S, Perrin A, Ayache D. Laryngeal dystonia. Rev Neurol 2003; 159: 916-922.
14. Kirton CA, Riopelle RJ. Meige syndrome secondary to basal ganglia injury: a potential cause of acute respiratory distress. Can J Neurol Sci 2001; 28: 167-173.
15. Opal P, Tintner R, Jankovic J, et al. Intrafamilial phenotypic variability of the DYT1 dystonia: from asymptomatic TOR1A gene carrier status to dystonic storm. Mov Disord 2002; 17: 339-345.
16. Mariotti P, Fasano A, Contarino MF, et al. Management of status dystonicus: our experience and review of the literature. Mov Disord 2007; 22: 963-968.
17. Muirhead W, Jalloh I, Vloeberghs M. Status dystonicus resembling the intrathecal baclofen withdrawal syndrome: a case report and review of the literature. J Med Case Rep 2010; 4: 294.
18. Santiago-Palma J, Hord ED, Vallejo R, Trella J, Ahmed SU. Respiratory distress after intrathecal baclofen withdrawal. Anesth Analg. 2004; 99: 227-229.
19. Hou JG, Ondo W, Jankovic J. Intrathecal baclofen for dystonia. Mov Disord 2001; 16: 1201-1202.
20. Papapetropoulos S, Papapetropoulos N, Singer C. Primary craniocervical dystonia presenting as a respiratory emergency. Neurology 2007; 68: 388-389.
21. Hamzei F, Rijntjes M, Gbadamosi J, Fuchs K, Weiller C, Münchau A. Life-threatening respiratory failure due to cranial dystonia after dental procedure in a patient with multiple system atrophy. Mov Disord 2003; 18: 959-961.